Heart and exercise capacity in Fabry disease
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how Anderson-Fabry disease affects your heart and ability to exercise. Researchers want to understand this better by testing your heart function and how well you can do physical activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed genetic diagnosis of Anderson-Fabry disease
- You are willing to sign a consent form (or have a caregiver sign if you are under 18)
- You can do an exercise test on a stationary bike
- You do not have severe kidney problems (eGFR below 30)
- You are not pregnant or breastfeeding
- You do not have a serious medical or mental health condition that would make it hard to understand the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise and physiotherapy program can improve fitness, stamina, and daily life for people with Anderson-Fabry disease. It is designed for people who are medically stable and able to join a gentle, progressive training program.
This study looks at people with Fabry disease, a genetic condition that can cause the heart muscle to thicken. Researchers want to understand how the heart's blood vessels change over time, which may help improve care for Fabry disease.
This study looks at how the heart is affected in adults with Fabry disease. It may help doctors better understand heart-related changes in order to guide care.
This study uses advanced heart scans (PET/CT and MRI) to look at inflammation, blood vessel health, and scarring in the hearts of people with Fabry disease. It aims to better understand how Fabry disease affects the heart and find new ways to track or treat these changes.
This study is creating a registry of people with Fabry disease to better understand how it affects the heart. By joining, you help doctors learn more about the condition and improve care for future patients.
This trial tests whether agalsidase alfa can reduce heart inflammation in people with Fabry disease who have heart problems. You may qualify if you have not had this treatment in the past year.
Hear when a new Anderson Fabry Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.